← FDA DRUG APPROVALS

FDA ANDA · ANDA214108

POTASSIUM CHLORIDE

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA214108
TYPE
ANDA
ORIGINAL APPROVAL
2022-03-24
LATEST ACTION
2022-03-24
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Prescription

Products

POTASSIUM CHLORIDEPrescription
POTASSIUM CHLORIDE 20MEQ · FOR SOLUTION · ORAL

Approval history

2022-03-24UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →